Tokyo, Aug. 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062429) titled 'Assessment of Cognitive Function in Patients with Eosinophilic Granulomatosis with Polyangiitis: Evaluation Using MoCA-J' on Aug. 3.
Study Type:
Observational
Primary Sponsor:
Institute - National Hospital Organization Sagamihara National Hospital
Condition:
Condition - Assessment of Cognitive Function in Patients with Eosinophilic Granulomatosis with Polyangiitis: Evaluation Using MoCA-J
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study is to determine the frequency of mild cognitive impairment in patients with eosinophilic granulomatosis with polyangiitis.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 50
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - EGPA Group
1.Patients diagnosed with EGPA based on the Lanham criteria.
2.Patients aged 50 years or older.
Control Asthma Group
1.Patients who participated in the previous study, "Oral corticosteroids as a risk factor for frailty in severe asthma" (all are asthma patients aged 60 years or older).
2.Patients evaluated using the MoCA-J.
Key exclusion criteria - Patients considered unsuitable for this study by the principal investigator.
Target Size - 50
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2026 Year 01 Month 27 Day
Date of IRB - 2026 Year 01 Month 27 Day
Anticipated trial start date - 2026 Year 08 Month 04 Day
Last follow-up date - 2028 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071448
Disclaimer: Curated by HT Syndication.
